Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
Not yet recruiting · NCT04405596 · Registry updated 2023-12-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia | Lewy body dementia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Not yet recruiting | Phase 1 / Phase 2 | 2023-12-13 | NCT04405596 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 148 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Parkwood Institute | London | Canada | 2 |